贫血和抑郁症的关联:系统性审查和元分析
Bhupesh Gupta1, Ramita Goel2, Vimal Satodiya3
1Maharishi Markandeshwar Institute of Medical Sciences and Research, Mullana, India.
Nigerian medical journal : journal of the Nigeria Medical Association
|December 31, 2025
概括
抑郁症影响了36%的贫血患者,在状细胞贫血和某些大陆的患者中,抑郁症的发病率更高. 早期查至关重要,特别是在年轻患者和资源有限的地区.
科学领域:
- 流行病学 流行病学
- 精神病学是一个精神病学.
- 血液学 血液学 血液学
背景情况:
- 贫血是一种影响不同人口的全球健康问题.
- 抑郁症是一种显著的并发症,可能对贫血管理产生影响.
- 了解贫血患者抑郁症的患病率对于综合护理至关重要.
研究的目的:
- 确定所有类型贫血患者中抑郁症的总体患病率.
- 调查不同类型贫血,年龄组,性别和地理区域中抑郁症患病率的变化.
- 为有针对性的查和干预策略提供证据.
主要方法:
- 对观察性流行病学研究进行了全面的元分析.
- 文献搜索包括PubMed,Scopus,Embase和谷歌学者 (2003-2024年) 在内.
- 用于元分析的随机效应模型;用于质量评估的JBI分数;用Q和I2统计数据评估异质性;使用漏斗图和埃格尔测试评估出版偏差.
主要成果:
- 贫血患者中抑郁症的综合患病率估计为36% (95% CI: 28-45%).
- 在状细胞贫血 (42%),血病 (35%) 和缺铁性贫血 (20%) 中观察到更高的患病率.
- 与美国 (28%) 和欧洲 (20%) 相比,亚洲 (40%) 和非洲 (37%) 的抑郁症率显著更高,年轻患者患病率增加.
结论:
- 很大一部分贫血患者患有抑郁症,需要临床治疗.
- 在贫血随访期间建议进行例行抑郁症查,特别是在高风险群体和资源有限的环境中.
- 对贫血中抑郁症的潜在机制和有效干预措施的进一步研究是有必要的.
相关概念视频
Depression: Overview
741
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
741
Depressive Disorders: Etiology
408
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
408
Depressive Disorders: MDD and Dysthymia
564
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
564
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Long-term Depression
3.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.0K
Antidepressant Drugs: MAOIs and Other Agents
765
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
765


